On 18 JUNE Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) said it will visit the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO) which occurred on The NASDAQ Stock Market. Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) performance is -8.67%. On last trading day company shares ended up $6.95. Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) distance from 50-day simple moving average (SMA50) is -12.01%.
On 26 JUNE BSD Medical Corporation (NASDAQ:BSDM) announced that it has entered into definitive agreements with institutional investors to raise approximately $5,225,000 in a registered direct offering at a price of $0.95 per unit. The Company is offering an aggregate of 5,500,000 shares of the Company’s common stock and warrants to purchase up to 4,400,000 shares of the Company’s common stock. BSD Medical Corporation (NASDAQ:BSDM) shares advanced 2.49% in last trading session and ended the day on $0.976. BSDM Gross Margin is 44.20% and its return on assets is -52.60%. BSD Medical Corporation (NASDAQ:BSDM) quarterly performance is -23.13%.
On 3 JUNE MELA Sciences Inc (NASDAQ:MELA) announced that it has initiated a study to examine the real-world clinical impact of MelaFind on dermatologists’ decision to biopsy pigmented skin lesions that are suspicious for melanoma. Darrell Rigel, MD, MS, Clinical Professor of Dermatology at New York University Langone Medical Center, will be the Principle Investigator for the study. MELA Sciences Inc (NASDAQ:MELA) shares moved down -7.10% in last trading session and was closed at $0.310, while trading in range of $0.31 – $0.35. MELA Sciences Inc (NASDAQ:MELA) year to date (YTD) performance is -51.56%.
On 27 JUNE CYANOTECH CORP (NASDAQ:CYAN) announced financial results for the fourth quarter and fiscal year 2014, ended March 31, 2014. For fiscal 2014 compared to fiscal 2013, net sales were $28,905,000 compared to $27,581,000, an increase of 5%. Gross profit was $11,564,000, with gross profit margin of 40%, compared to gross profit of $10,958,000 and gross profit margin of 40%. Operating income for the year was $165,000 compared to $2,299,000 for fiscal 2013. CYANOTECH CORP (NASDAQ:CYAN) ended the last trading day at $4.41. Company weekly volatility is calculated as 5.32% and price to cash ratio as 9.68. CYANOTECH CORP (NASDAQ:CYAN) showed a negative weekly performance of -8.13%.
On 26 JUNE ZS Pharma Inc (NASDAQ:ZSPH) said that ZS Pharma Inc (NASDAQ:ZSPH) Insider A/S Novo purchased 275,000 shares of ZS Pharma stock on the open market in a transaction. The shares were purchased at an average cost of $18.00 per share, for a total transaction of $4,950,000.00. Following the completion of the acquisition, the insider now directly owns 781,730 shares of the company’s stock, valued at approximately $14,071,140. The purchase was disclosed in a filing with the Securities & Exchange Commission. ZS Pharma Inc (NASDAQ:ZSPH) weekly performance is -1.67%. On last trading day company shares ended up $27.15. ZS Pharma Inc (NASDAQ:ZSPH) distance from 50-day simple moving average (SMA50) is -4.30%.